Lite Strategy (LITS) Interest Coverage Ratio (2011 - 2026)
Lite Strategy (LITS) posted quarterly Interest Coverage Ratio of 25.79 for Q1 2026, down 409.43% year-over-year from 8.33 in Q1 2025, and up 26.52% quarter-over-quarter from 35.1 in Q4 2025.
Lite Strategy (LITS) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Lite Strategy's Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 25.79 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 409.43% year-over-year to 25.79; the TTM figure through Mar 2026 stood at 25.93 (down 916.7% YoY), while the FY2025 annual figure was 0.24, down 122.17% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 25.79, up from 35.1 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 16.21 in Q3 2023, with the low at 1246.33 in Q3 2025.
- The 5-year median for Interest Coverage Ratio is 16.83 (2024), against an average of 87.41.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio sank 14692.6% in 2022, then jumped 1707.95% in 2023.
- Lite Strategy's Interest Coverage Ratio stood at 2.16 in 2022, then slumped by 1049.11% to 20.46 in 2023, then surged by 56.65% to 8.87 in 2024, then slumped by 295.61% to 35.1 in 2025, then gained by 26.52% to 25.79 in 2026.
- Business Quant data shows LITS's Interest Coverage Ratio at 25.79 in Q1 2026, 35.1 in Q4 2025, and 1246.33 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Lite Strategy | 33.69 Mn | 26.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.79 |
| Dec 31, 2025 | -35.10 |
| Sep 30, 2025 | -1,246.33 |
| Jun 30, 2025 | -0.04 |
| Mar 31, 2025 | -5.06 |
| Dec 31, 2024 | -8.87 |
| Sep 30, 2024 | -23.39 |
| Jun 30, 2024 | -1.60 |
| Mar 31, 2024 | -16.83 |
| Dec 31, 2023 | -20.46 |
| Sep 30, 2023 | 16.21 |
| Jun 30, 2023 | -19.54 |
| Mar 31, 2023 | -0.97 |
| Dec 31, 2022 | 2.16 |
| Sep 30, 2022 | -1.01 |
| Jun 30, 2022 | -42.62 |
| Mar 31, 2022 | -56.73 |
| Dec 31, 2021 | -5.12 |
| Sep 30, 2021 | -4.87 |
| Jun 30, 2021 | -0.29 |